Fecal sulfatide as a non-invasive biomarker for predicting coronary heart disease
Fecal sulfatide may serve as a novel, non-invasive biomarker for early coronary heart disease prediction and risk stratification. However, the retrospective and single-center design of this study limits the generalizability of the results, and future large-scale, multi-center prospective studies are needed to validate these findings.
Authors
- Kefan Xue (ORCID: https://orcid.org/0000-0002-2500-1574)
- Ran Guo
- Xiao Hu
- Hongxia Guo
- Rui Hu
- Gang Li
- Yihan Li
Institutions
- Hebei Medical University (CN)
- Beijing Geriatric Hospital (CN)
- Second Hospital of Hebei Medical University (CN)
- Hebei General Hospital (CN)
- Beijing Hospital (CN)
- Hebei Institute of Physical Education (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1186/s40001-025-03726-6
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00